1 / 94

Fellow Seminar

Fellow Seminar. Topic: Vitamin D: a pleiotropic hormone Comment ：洪振傑 醫師 報告人員： F2 張春偉 報告時間： 99-09-15. OUTLINE. VITAMIN D – NORMAL METABOLISM VITAMIN D IN BONE & CALCIUM HOMEOSTASIS VITAMIN D & CANCER VITAMIN D AS IMMUNE MODULATOR CARDIOVASCULAR & METABOLIC ACTIONS RENAL PROTECTION

miriam-love
Download Presentation

Fellow Seminar

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Fellow Seminar • Topic: Vitamin D: a pleiotropic hormone Comment ：洪振傑 醫師 報告人員：F2 張春偉 報告時間：99-09-15

  2. OUTLINE • VITAMIN D – NORMAL METABOLISM • VITAMIN D IN BONE & CALCIUM HOMEOSTASIS • VITAMIN D & CANCER • VITAMIN D AS IMMUNE MODULATOR • CARDIOVASCULAR & METABOLIC ACTIONS • RENAL PROTECTION • CLINICAL PERSPECTIVES

  3. VITAMIN D - NORMAL METABOLISM

  4. In kidney, mitochondria of epithelial cells in the proximal nephron reabsorption of 25-hydroxyvitamin D + DBP from tubular fluid • By megalin-dependent mechanism • Calcitriol is then released into peritubular blood • Circulates in plasma again bound to DBP

  5. Vitamin D binding protein • DBP • ~ 58-kDa protein synthesized in the liver • Human serum levels: 4 - 8 μM • Half life: 3 days • The parent vitamin D, 25(OH)D, & 1,25(OH)2D are carried in the circulation by DBP • But the greatest affinity is for 25(OH)D

  6. Vitamin D binding protein • Primary role • Maintain stable serum stores of vitamin D metabolites & modulate the rates of bioavailability, activation, & end organ responsiveness • Deficiency of DBP • Occur in nephrotic syndrome due to urinary protein losses • Leading to low 25(OH)D serum levels

  7. Genomic mechanism • At the cellular level, receptor (megalin)–mediated endocytosis of both calcidiol & calcitriol • Inside the cell, 1,25(OH)2D • Inactivated by mitochondrial 24-hydroxylase • Or bind to the VDR in the cytoplasm • VDR-ligand binding occurred => VDR translocates to the nucleus • => Heterodimerizes with the retinoid X receptor

  8. Genomic mechanism • This complex binds the vitamin D response element of target genes • Recruits transcription factors & corepressors/activators that modulate the transcription • These corepressors & coactivators appear to be specific for the ligand • Different forms & analogs of vitamin D may produce different effects

  9. Nongenomic • Exert biologic effects over periods of time that are too short to be explained by genomic mechanisms • A discrete receptor, or membrane-associated protein • Distinct from the VDR may mediate these rapid nongenomic actions

  10. Transcaltachia • Increases in intestinal Ca transport within 10 - 15 minutes after adding 1,25-dihydroxyvitamin D to fluid used to perfuse the lumen of the proximal small intestine

  11. Impact of Chronic Kidney Disease on Vitamin D Metabolism • Cross-sectional studies • 1,25-dihydroxyvitamin D decrease progressively as renal function declines • Reductions in renal synthesis • Adversely affects intestinal Ca absorption => modest reductions in serum Ca concentration • => Hypocalciuria • Several mechanisms involved

  12. Consequences of Impaired Renal Calcitriol Synthesis in Chronic Kidney Disease • Calcitriol modulates the expression of several key proteins responsible for the transepithelial movement of Ca • Not only in intestine but also in kidney • Calbindins • Vitamin D-dependent proteins • Buffer free Ca within the cytoplasm of epithelial cells in Ca-transporting epithelia • Translocation of Ca from the apical to the basolateral cell membrane

  13. Calcitriol + Ca modulates the expression of 2 proteins • Vanilloid family of transient receptor potential (TRP) proteins • TRPV-5 & TRPV-6 • Constitutively activated Ca channel • Mediates Ca uptake across the apical membrane of renal & intestinal epithelial cells

  14. Extrarenal Calcitriol Synthesis • Other tissues also express the 25-hydroxyvitamin D-1-α-hydroxylase • => 1,25-dihydroxyvitamin D synthesis regulated in a tissue-specific manner • => serve as autocrine or paracrine

  15. VITAMIN D IN BONE & CALCIUM HOMEOSTASIS

  16. 1,25(OH)2D3 • Major calcitropic hormone • Keep the plasma Ca2+ within narrow limits • Renal production regulated by 2 hormones • PTH • Hypocalcemia => secretion of PTH by the parathyroid gland • PTH targets the kidney • Decrease Ca2+ excretion, inhibit phosphate reabsorption, & stimulate 1,25(OH)2D3 production

  17. FGF23 • 1,25(OH)2D3 stimulates the secretion of FGF23 by the osteocytes • Major phosphaturic hormone • Inhibiting renal phosphate reabsorption • By the specific transporter NaPiT2a • Decrease renal production of 1,25(OH)2D3

  18. Genetic deficiencies in 1,25(OH)2D3 • Loss of CYP27B1 or VDR • => hypocalcemia, hyperparathyroidism, hypophoshatemia, rickets, & osteomalacia • The phenotype can largely be corrected by administration of a high Ca diet • Bypasses 1,25(OH)2D3 -mediated, Ca2+ absorption - Endocr Rev 2008;29: 726–776

  19. Reintroducing VDR in the intestine of VDR null mice rescued the hypocalcemia & the bone phenotype - Gastroenterology 2009; 136:1317–1327 - J Bone Miner Res 2008; 23: S104 • The proteins involved in this active intestinal Ca2+ transport remain poorly defined.

  20. TRPV6, Calbindin • Main mediators of 1,25(OH)2D3 -induced intestinal Ca2+ absorption • Inactivation of TRPV6 & calbindin D9k not impair intestinal Ca2+ absorption when dietary Ca intake is normal • => compensatory proteins

  21. TRPV6 is critical for Ca2+ absorption when dietary Ca intake is low • Impaired intestinal Ca2t absorption in TRPV6 null mice on a low Ca diet - J Bone Miner Res 2007; 22: 274–285 - Endocrinology 2008; 149: 3196–3205

  22. Hypothesis: 1,25(OH)2D3 action not only affects transcellular but also paracellular Ca2+ transport • Regulate tight junction permeability in the intestine by modifying the expression of several tight junction proteins • Claudin-2 & claudin-12 - Mol Biol Cell 2008; 19: 1912–1921

  23. TRPV5 is definitely critical for renal Ca2+ reabsorption • TRPV5 null mice • Profound Ca2+ wasting • With compensatory increased intestinal Ca2+ absorption • Due to high 1,25(OH)2D3 serum levels, & normocalcemia as a result - J Clin Invest 2003; 112: 1906–1914

  24. Direct effect of 1,25(OH)2D3 on bone homeostasis? • 1,25(OH)2D3 stimulate bone resorption • Increasing the expression of osteoclastogenic factors in osteoblasts • Receptor activator of nuclear factor kB ligand • 1,25(OH)2D3 -mediated signaling in regulating the activity of chondrocytes & osteoblasts • During endochondral bone formation & bone homeostasis

  25. Aberrant growth plate development in VDR-deficient mice appears before the onset of hypocalcemia • High Ca diet corrected all aspects of the phenotype of CYP27B1-deficient mice, except long bone growth - Endocr Rev 2008;29: 726–776

  26. Mice lacking VDR expression in chondrocytes • Normal growth plate • But develop a transient phenotype of increased bone volume postnatally • Due to decreased expression of the angiogenic factor VEGF & the osteoclastogenic factor receptor activator of nuclear factor kB ligand in chondrocytes - J Clin Invest 2006; 116: 3150–3159

  27. 1,25(OH)2D3 -mediated signaling in chondrocytes • Necessary for timely vascular invasion & osteoclastogenesis during bone growth

  28. VITAMIN D & CANCER

  29. Several large-scale epidemiological studies have shown an inverse correlation between exposure to sunlight (the major source of vitamin D) or vitamin D intake & risk of colorectal, breast, & prostate cancer

  30. Colorectal cancer risk • Am J Prev Med 2007; 32: 210–216 • Meta-analysis • 51% lower incidence of colorectal ca • Highest serum 25(OH)D3 quintile (82 nmol/l) compared to the lowest quintile (<=30 nmol/l) • Aliment Pharmacol Ther 2009; 30:113–125 • Meta-analysis • Lower serum 25(OH)D3 inversely associated with colorectal cancer

  31. Am J Prev Med 2007; 32: 210–216

  32. Am J Prev Med 2007; 32: 210–216

  33. Aliment Pharmacol Ther 2009; 30:113–125

  34. NEJM 2006; 354: 684–696 • Randomized, double-blind, placebo-controlled trial involving 36,282 postmenopausal women from 40 Women’s Health Initiative centers, combined treatment of vitamin D3 (400 IU per day) & Ca • Not decrease colon cancer risk • Am J Clin Nutr 2007; 85: 1586–1591 • Much smaller RCT • 1100 IU per day of vitamin D3 + Ca • Decreased the overall cancer risk

  35. Am J Clin Nutr 2007; 85: 1586–1591 RR=0.232, P<0.005 RR=0.587, P=0.147

  36. Breast cancer risk • Positive study in the US & Europe • Best Pract Res Clin Endocrinol Metab 2008; 22: 587–599 • UK • Women with 25(OH)D3 levels < 50nmol/l OR=3.54 for breast cancer risk compared with women with levels >50 nmol/l • Negative in other epidemiological studies

  37. Cancer Epidemiol Biomarkers Prev 2005; 14: 1991–1997

  38. Prostate cancer • Association with 25(OH)D3 status less clear than for colorectal cancer • Overall cancer outcome • Association remains ambiguous

  39. Am J Epidemiol 2009; 169:1223–1232

More Related